GSE233679 nicotinamide 14 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679_nicotinamide_14_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679_nicotinamide_14_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679_nicotinamide_14_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679_nicotinamide_14_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

FOXD2 adjacent opposite strand RNA 1

Gene

P4HA2 antisense RNA 1

Gene

uncharacterized LOC102724684

Gene

RNA, 7SL, cytoplasmic 166, pseudogene

Gene

FHAD1 antisense RNA 1

Gene

FARSA antisense RNA 1

Gene

family with sequence similarity 27 member B

Gene

RNA, 7SL, cytoplasmic 219, pseudogene

Gene

ribosomal protein L21 pseudogene 97

Gene

RPS27A pseudogene 16

  • Gene

    FOXD2 adjacent opposite strand RNA 1


  • Gene

    P4HA2 antisense RNA 1


  • Gene

    uncharacterized LOC102724684


  • Gene

    RNA, 7SL, cytoplasmic 166, pseudogene


  • Gene

    FHAD1 antisense RNA 1


  • Gene

    FARSA antisense RNA 1


  • Gene

    family with sequence similarity 27 member B


  • Gene

    RNA, 7SL, cytoplasmic 219, pseudogene


  • Gene

    ribosomal protein L21 pseudogene 97


  • Gene

    RPS27A pseudogene 16

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.